Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Vidal, D; Matias-Guiu, X; Alomar, A

    Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis

    BRITISH JOURNAL OF DERMATOLOGY 151 656-662. .

    [doi:10.1111/j.1365-2133.2004.06094.x]

  • Toll, A; Gilaberte, M; Matias-Guiu, X; Camacho, L; Alomar, A; Gonzalez-Gay, MA; Pujol, RM

    Kikuchi's disease (necrotizing lymphadenitis) with cutaneous involvement associated with subacute cutaneous lupus erythematosus

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 29 240-243. .

    [doi:10.1111/j.1365-2230.2004.01454.x]

  • Moreno-Bueno, G; Hardisson, D; Prat, J; Matias-Guiu, J; Palacios, J

    Re: Scholten et al. nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201 : 460-465

    JOURNAL OF PATHOLOGY 202 511-512. .

    [doi:10.1002/path.1540]

  • Trovisco, V; de Castro, IV; Soares, P; Maximo, V; Silva, P; Magalhaes, J; Abrosimov, A; Guiu, XM; Sobrinho-Simoes, M

    BRaF mutations are associated with some histological types of papillary thyroid carcinoma

    JOURNAL OF PATHOLOGY 202 247-251. .

    [doi:10.1002/path.1511]

  • Valenzuela, N; Barnadas, MA; Matias-Guiu, X; Curell, R; de Andres, L; Alomar, A

    Lethal perianal Buschke-Lowenstein tumor in a female patient with aIDS

    Dermatology 208 349-350. .

    [doi:10.1159/000077847]

  • Pallares, J; Perez-Ruiz, L; Ros, S; Panades, J; Pardo-Mindan, J; Lloreta, J; Matias-Guiu, X

    Malignant peripheral nerve sheath tumor of the thyroid: a clinicopathological and ultrastructural study of one case.

    ENDOCRINE PATHOLOGY 15 167-174. .

    [doi:10.1385/EP:15:2:167]

  • Moreno-Bueno, G; Sanchez-Estevez, C; Cassia, R; Rodriguez-Perales, S; Diaz-Uriarte, R; Dominguez, O; Hardisson, D; Andujar, M; Prat, J; Matias-Guiu, X; Cigudosa, JC; Palacios, J

    Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas

    CANCER RESEARCH 63 5697-5702. .

  • Alvarez-Nunez, F; Mora, J; Matias-Guiu, X; Grp Estudio Marcadores Tumorales

    Thyroid carcinomas of the follicular epithelium: tumor markers and oncogenes

    MEDICINA CLINICA 121 264-269. .

    [doi:10.1157/13050439]

  • Moreno-Bueno, G; Rodriguez-Perales, S; Sanchez-Estevez, C; Hardisson, D; Sarrio, D; Prat, J; Cigudosa, JC; Matias-Guiu, X; Palacios, J

    Cyclin D1 gene (CCND1) mutations in endometrial cancer

    ONCOGENE 22 6115-6118. .

    [doi:10.1038/sj.onc.1206868]

  • Bellido, M; Aventin, A; Lasa, A; Estivill, C; Carnicer, MJ; Pons, C; Matias-Guiu, X; Bordes, R; Baiget, M; Sierra, J; Nomdedeu, JF

    Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia

    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 88 994-1001. .

  • Ota, S; Catasus, L; Matias-Guiu, X; Bussaglia, E; Lagarda, H; Pons, C; Munoz, J; Kamura, T; Prat, J

    Molecular pathology of atypical polypoid adenomyoma of the uterus

    HUMAN PATHOLOGY 34 784-788. .

    [doi:10.1016/S0046-8177(03)00246-6]

  • Moreno-Bueno, G; Hardisson, D; Sarrio, D; Sanchez, C; Cassia, R; Prat, J; Herman, JG; Esteller, M; Matias-Guiu, X; Palacios, L

    Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120(ctn)) expression in endometrial cancer and endometrial atypical hyperplasia

    JOURNAL OF PATHOLOGY 199 471-478. .

    [doi:10.1002/path.1310]

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU